New statins under clinical development: nisvastatin and rosuvastatin
Yamamoto, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 605-608
2001
ISSN/ISBN: 0047-1852 PMID: 11347140 Document Number: 526820
Document emailed within 1 workday
Related Documents
Martin, P.; Gillen, M.; Ritter, J.; Mathews, D.; Brealey, C.; Surry, D.; Oliver, S.; Holmes, V.; Severin, P.; Elsby, R. 2016: Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results from Phase i Clinical Studies Drugs in R&d 16(1): 93-107Moura, L.M.; Ramos, S.F.; Kristensen, S.D.; Pinto, F.J.; Barros, I.M.; Rocha-Gonçalves, F. 2012: Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis Journal of Heart Valve Disease 21(4): 463-472
Schweiger, C. 2003: Clinical trials with rosuvastatin: efficacy and safety of its use Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(Suppl 7): 33s-46s
2003: Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins Prescrire International 12(66): 143-148
Gao, R-lin. 2007: The efficacy and safety of rosuvastatin on treating patients with hypercholesterolemia in Chinese: a randomized, double-blind, multi-center clinical trial Zhonghua Xin Xue Guan Bing Za Zhi 35(3): 207-211
Biasucci, L.M.; Stefanelli, A.; Biasillo, G. 2012: Statins and coronary artery disease: clinical evidence and future perspective Minerva Cardioangiologica 60(2): 147-156
Drobny, M.; Pullmann, R.; Odalos, I.; Skerenova, M.; Saniova, B. 2014: Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture Neuro Endocrinology Letters 35(2): 123-128
Cherkanova, M.S.; Korolenko, T.A.; Bravve, I.I.; Gerasimova, T.P. 2012: Effect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients after coronary artery bypass surgery Kardiologiia 52(2): 23-28
Kelloff, G.J.; Crowell, J.A.; Boone, C.W.; Steele, V.E.; Lubet, R.A.; Greenwald, P.; Alberts, D.S.; Covey, J.M.; Doody, L.A.; Knapp, G.G. 1994: Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute Journal of Cellular Biochemistry. Supplement 20: 55-62
Kassimatis, T.I.; Konstantinopoulos, P.A. 2009: Rosuvastatin in patients undergoing hemodialysis New England Journal of Medicine 361(1): 93; Author Reply 94-95
Bousquet, P.; Gayet, J-Louis. 2003: Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor Therapie 58(2): 113-121
Zipes, D.P.; Zvaifler, N.J.; Glassock, R.J.; Gilman, S.; Muñoz, A.; Gogolak, V.; Gordis, L.; Dedon, P.C.; Guengerich, F.P.; Wasserman, S.I.; Witztum, J.L.; Wogan, G.N. 2006: Rosuvastatin: an independent analysis of risks and benefits Medgenmed: Medscape General Medicine 8(2): 73
Ivleva, A.I. 2005: Efficacy of lipid correcting therapy with the use of rosuvastatin Kardiologiia 45(6): 71-80
Wander, G.S.; Hukkeri, M.Yunus.Khan.; Yalagudri, S.; Mahajan, B.; Panda, A.Toppo. 2018: Rosuvastatin: Role in Secondary Prevention of Cardiovascular Disease Journal of the Association of Physicians of India 66(3): 70-74
Ullah, F.; Afridi, A.K.; Rahim, F.; ur Rahman, S.; Ashfaq, M. 2015: Efficacy of 5 Mg and 10 Mg Rosuvastatin in Type-2 Diabetes Mellitus with Hypercholesteroalemia Journal of Ayub Medical College Abbottabad: Jamc 27(3): 564-568
Ott, C.; Ritt, M.; Titze, S.I.; Schäufele, T.; Schmieder, R.E. 2009: Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia Journal of Nephrology 22(5): 675-681
Gogolashvili, N.G. 2012: Atorvastatin or rosuvastatin? Select from the perspective of evidence-based medicine Kardiologiia 52(7): 84-92
Drapkina, O.M.; Eliashevich, S.O. 2015: Efficacy and Safety of Rosuvastatin in Patients of Different Risk Groups of Developing Cardiovascular Kardiologiia 55(2): 72-81
Li, W.; Huang, H.-y.; Wu, Z.-y.; Xie, F.-q.; Zhang, X.-r.; Guan, P. 2009: Rosuvastatin attenuates vascular endothelial adhesiveness in apolipoprotein E-deficient mice Zhonghua Xin Xue Guan Bing Za Zhi 37(1): 69-72
Mehta, T.N.; Patel, A.K.; Kulkarni, G.M.; Suubbaiah, G. 2005: Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC method Journal - Association of Official Analytical Chemists 88(4): 1142-1147